In Vivo is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
E. Merck acquires 51% of generics holding company Amerpharm
09 May 2002
E. Merck acquired 51% of the generics holding company Amerpharm and will acquire the remaining shares over the next several years, in part to incentivize Amerpharm CEO Tony Tabatznik to continue to build the business.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?